The Automated Screening Working Groups is a group of software engineers and biologists passionate about improving scientific manuscripts on a large scale. Our members have created tools that check for common problems in scientific manuscripts, including information needed to improve transparency and reproducibility. We have combined our tools into a single pipeline, called ScreenIT. We're currently using our tools to screen COVID preprints.

About Followers

Latest preprint reviews

  1. B.1.526 SARS-CoV-2 Variants Identified in New York City are Neutralized by Vaccine-Elicited and Therapeutic Monoclonal Antibodies

    1. Hao Zhou
    2. Belinda M. Dcosta
    3. Marie I. Samanovic
    4. Mark J. Mulligan
    5. Nathaniel R. Landau
    6. Takuya Tada

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. The SARS-CoV2 envelope differs from host cells, exposes procoagulant lipids, and is disrupted in vivo by oral rinses

    1. Zack Saud
    2. Victoria J. Tyrrell
    3. Andreas Zaragkoulias
    4. Majd B. Protty
    5. Evelina Statkute
    6. Anzelika Rubina
    7. Kirsten Bentley
    8. Daniel A. White
    9. Patricia Dos Santos Rodrigues
    10. Robert C. Murphy
    11. Harald Köfeler
    12. William J. Griffiths
    13. Jorge Alvarez-Jarreta
    14. Richard William Brown
    15. Robert G. Newcombe
    16. James Heyman
    17. Manon Pritchard
    18. Robert WJ. Mcleod
    19. Arvind Arya
    20. Ceri-Ann Lynch
    21. David Owens
    22. P Vince Jenkins
    23. Niklaas J. Buurma
    24. Valerie B. O’Donnell
    25. David W. Thomas
    26. Richard J. Stanton

    Reviewed by ScreenIT

    3 evaluationsAppears in 1 listLatest version Latest activity

  3. SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies

    1. Markus Hoffmann
    2. Prerna Arora
    3. Rüdiger Groß
    4. Alina Seidel
    5. Bojan F. Hörnich
    6. Alexander S. Hahn
    7. Nadine Krüger
    8. Luise Graichen
    9. Heike Hofmann-Winkler
    10. Amy Kempf
    11. Martin S. Winkler
    12. Sebastian Schulz
    13. Hans-Martin Jäck
    14. Bernd Jahrsdörfer
    15. Hubert Schrezenmeier
    16. Martin Müller
    17. Alexander Kleger
    18. Jan Münch
    19. Stefan Pöhlmann

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. In vitro inactivation of SARS-CoV-2 with 0.5% povidone iodine nasal spray (Nasodine) at clinically relevant concentrations and timeframes using tissue culture and PCR based assays

    1. S.P. Tucker
    2. S. Goodall
    3. J. Julander
    4. M. Mendenhall
    5. P. Friedland
    6. P.L. Molloy

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. SARS-CoV-2 acquisition and immune pathogenesis among school-aged learners in four diverse schools

    1. Dan M. Cooper
    2. Michael Z. Zulu
    3. Allen Jankeel
    4. Izabela Coimbra Ibraim
    5. Jessica Ardo
    6. Kirsten Kasper
    7. Diana Stephens
    8. Andria Meyer
    9. Annamarie Stehli
    10. Curt Condon
    11. Mary E. Londoño
    12. Casey M. Schreiber
    13. Nanette V. Lopez
    14. Ricky L. Camplain
    15. Michael Weiss
    16. Charles Golden
    17. Shlomit Radom-Aizik
    18. Bernadette Boden-Albala
    19. Clayton Chau
    20. Ilhem Messaoudi
    21. Erlinda R. Ulloa

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Value-based pricing of a COVID-19 vaccine

    1. Afschin Gandjour

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants

    1. Yiska Weisblum
    2. Fabian Schmidt
    3. Fengwen Zhang
    4. Justin DaSilva
    5. Daniel Poston
    6. Julio CC Lorenzi
    7. Frauke Muecksch
    8. Magdalena Rutkowska
    9. Hans-Heinrich Hoffmann
    10. Eleftherios Michailidis
    11. Christian Gaebler
    12. Marianna Agudelo
    13. Alice Cho
    14. Zijun Wang
    15. Anna Gazumyan
    16. Melissa Cipolla
    17. Larry Luchsinger
    18. Christopher D Hillyer
    19. Marina Caskey
    20. Davide F Robbiani
    21. Charles M Rice
    22. Michel C Nussenzweig
    23. Theodora Hatziioannou
    24. Paul D Bieniasz

    Reviewed by ScreenIT

    2 evaluationsAppears in 1 listLatest version Latest activity

  8. Homologous and heterologous serological response to the N-terminal domain of SARS-CoV-2

    1. Huibin Lv
    2. Owen Tak-Yin Tsang
    3. Ray T. Y. So
    4. Yiquan Wang
    5. Meng Yuan
    6. Hejun Liu
    7. Garrick K. Yip
    8. Qi Wen Teo
    9. Yihan Lin
    10. Weiwen Liang
    11. Jinlin Wang
    12. Wilson W. Ng
    13. Ian A. Wilson
    14. J. S. Malik Peiris
    15. Nicholas C. Wu
    16. Chris K. P. Mok

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding

    1. Tyler N. Starr
    2. Allison J. Greaney
    3. Sarah K. Hilton
    4. Daniel Ellis
    5. Katharine H.D. Crawford
    6. Adam S. Dingens
    7. Mary Jane Navarro
    8. John E. Bowen
    9. M. Alejandra Tortorici
    10. Alexandra C. Walls
    11. Neil P. King
    12. David Veesler
    13. Jesse D. Bloom

    Reviewed by ScreenIT

    2 evaluationsAppears in 1 listLatest version Latest activity

  10. An ACE2 Triple Decoy that neutralizes SARS-CoV-2 shows enhanced affinity for virus variants

    1. Shiho Tanaka
    2. Gard Nelson
    3. C. Anders Olson
    4. Oleksandr Buzko
    5. Wendy Higashide
    6. Annie Shin
    7. Marcos Gonzalez
    8. Justin Taft
    9. Roosheel Patel
    10. Sofija Buta
    11. Ashley Richardson
    12. Dusan Bogunovic
    13. Patricia Spilman
    14. Kayvan Niazi
    15. Shahrooz Rabizadeh
    16. Patrick Soon-Shiong

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Newer Page 2287 of 2361 Older